Alaunos Therapeutics Inc (TCRT) — Cash Flow-to-Debt Ratio
Alaunos Therapeutics Inc (TCRT) has a Cash Flow-to-Debt Ratio of -0.68x as of December 2025, meaning its operating cash flow of $-552.00K could theoretically repay -1% of its total liabilities ($813.00K) in one year. Check TCRT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Alaunos Therapeutics Inc Cash Flow-to-Debt Ratio (2001–2025)
Historical debt coverage capacity for Alaunos Therapeutics Inc across 25 annual periods. Also explore Alaunos Therapeutics Inc asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Alaunos Therapeutics Inc (2001–2025)
Year-by-year debt coverage analysis for Alaunos Therapeutics Inc. For market capitalisation and broader financial context, see Alaunos Therapeutics Inc (TCRT) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -3.53x | $-2.87 Million | $813.00K | ▲ +50.9% |
| 2024 | -7.18x | $-4.97 Million | $692.00K | ▲ +53.4% |
| 2023 | -15.41x | $-30.14 Million | $1.96 Million | ▼ -1290.8% |
| 2022 | -1.11x | $-29.23 Million | $26.38 Million | ▲ +33.6% |
| 2021 | -1.67x | $-61.47 Million | $36.81 Million | ▲ +34.5% |
| 2020 | -2.55x | $-57.01 Million | $22.36 Million | ▲ +12.0% |
| 2019 | -2.90x | $-40.85 Million | $14.10 Million | ▲ +44.4% |
| 2018 | -5.21x | $-49.46 Million | $9.49 Million | ▼ -1830.2% |
| 2017 | -0.27x | $-54.67 Million | $202.41 Million | ▲ +15.0% |
| 2016 | -0.32x | $-58.33 Million | $183.65 Million | ▼ -210633.6% |
| 2015 | 0.00x | $-10.00K | $66.35 Million | ▲ +100.0% |
| 2014 | -3.22x | $-36.65 Million | $11.40 Million | ▼ -20.9% |
| 2013 | -2.66x | $-59.51 Million | $22.37 Million | ▼ -18.0% |
| 2012 | -2.25x | $-78.83 Million | $34.96 Million | ▼ -111.9% |
| 2011 | -1.06x | $-38.84 Million | $36.50 Million | ▼ -67.3% |
| 2010 | -0.64x | $-19.69 Million | $30.97 Million | ▼ -11.9% |
| 2009 | -0.57x | $-12.29 Million | $21.63 Million | ▲ +85.9% |
| 2008 | -4.03x | $-23.52 Million | $5.83 Million | ▼ -18.4% |
| 2007 | -3.41x | $-21.65 Million | $6.36 Million | ▲ +29.6% |
| 2006 | -4.84x | $-14.42 Million | $2.98 Million | ▼ -26.3% |
| 2005 | -3.83x | $-8.78 Million | $2.29 Million | ▼ -1003.4% |
| 2004 | -0.35x | $-7.31K | $21.05K | ▲ +4.2% |
| 2003 | -0.36x | $-9.33K | $25.72K | ▲ +45.0% |
| 2002 | -0.66x | $-11.77K | $17.84K | ▲ +88.0% |
| 2001 | -5.50x | $-30.26K | $5.50K | — |